Navigation Links
US Prescription Drug Market Worth $457.3 Billion by 2021 Says Healthcare Policy Update Report at RnRMarketResearch.com
Date:12/9/2013

Dallas, TX (PRWEB) December 09, 2013

On June 28, 2012, after months of suspense, the US Supreme Court announced its decision on the constitutionality of the Patient Protection and Affordable Care Act (PPACA) (referred to hereafter, as “ACA” or “the Act”). The Court, led by Chief Justice John Roberts, ruled that the individual mandate, which compels individuals to purchase health insurance, is constitutional as a form of taxation. However, the Court also ruled that states do not have to expand Medicaid coverage – a key provision of the Act – for fear of facing withdrawn federal funding for the program as earlier threatened by the federal government (Supreme Court, 2012).

The healthcare landscape for payers, pharmaceutical and medical devices companies, and providers is expected to change remarkably over the next few years due to the various provisions of the ACA, some of which have already been implemented. The Act is expected to extend insurance coverage to approximately 25 million previously uninsured individuals by 2023 (CBO, 2013). Although this potentially increases top-line revenue growth for all players, new rebates, taxes, cuts, and fees are poised to decrease margins.

Complete report is available @ http://www.rnrmarketresearch.com/pharmasphere-us-healthcare-policy-update-impact-analysis-of-the-affordable-care-act-on-stakeholders-market-report.html .

Universal Coverage: A Little Farther than Thought
When the ACA was passed, the Congressional Budget Office (CBO) estimated that 30 million previously uninsured individuals would have access to healthcare. However, the Supreme Court’s decision labeling the federal government’s threat to deny states Medicaid funding if they fail to expand Medicaid coverage as unconstitutional, has caused the CBO to revisit its earlier estimates. According to the CBO’s latest forecast, about 25 million previously uninsured people will be insured by 2023, which is 16.7% less than the 30 million initially expected. Furthermore, it is estimated that Medicaid enrollment will increase by only seven million people by 2014, which is 46.2% less than the 13 million enrollees initially expected (CBO, 2012). Consequently, a projected 31 million people will still be left without insurance by 2023. This includes undocumented workers and low-income persons living in the 26 states that have thus far, declined to expand Medicaid, including Virginia – a state known for having one of the strictest Medicaid eligibility standards in the US. If fully implemented, the ACA will potentially halve the number of uninsured individuals in the US – a significant improvement, no doubt – but this alone, will not completely solve the problem of a lack of universal healthcare coverage in the US.

Imminent Surge in Prescription Drug Spending
Prescription drug spending will increase in the US. According to the Centers for Medicare & Medicaid Services (CMS), prescription drug expenditures will increase by 74.4% from $274.8 billion in 2012 to $457.3 billion in 2021 with the implementation of the ACA’s provisions; this increase represents a larger expected growth than would be seen without the implementation of the Act. The key drivers for this additional growth are expected increases in the volume of individual and group insurance coverage, as well as coverage expansions, primarily with Medicaid. Although the government plans to fund most of the added costs resulting from coverage expansions with new taxes, fees, and rebates imposed by the ACA, the worrisome growth in US healthcare expenditures – with a forecast close to $4.7 trillion in 2021 spending alone – does not show signs of abating (CMS, 2012a). This, combined with the relatively slow growth of the country’s Gross Domestic Product (GDP) in recent years, does not paint a pretty picture of things to come unless the economy shows tremendous improvement over the next few years.

Difficult Times on the Horizon for Healthcare Providers
The sustainable growth rate (SGR) formula, used by the government to check physician payments under Medicare, is poised to reset to its lower, statutory target if Congress does not act before January 1, 2014. Since 2003, Congress has used various methods, including freezes, to temporarily block the SGR formula from going into effect. Based on information emanating from the American Medical Association (AMA), if the SGR resets, it will automatically result in a 24.4% reduction in reimbursement levels in 2014, which is unwelcome news for providers.

According to the AMA, the cost of patient care has increased by 25% since 2001, while physician Medicare payments have increased by only 4% (excluding the 2% cut from sequestration) (AMA, 2013). With various other cuts such as reductions in Medicare and Medicaid Disproportionate Share Hospital (DSH) payments, and a 1% decrease in Medicare payments for hospital acquired infections targeted at healthcare providers, healthcare providers will need to tighten up on their spending.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=133699 .

Browse more reports on Policy Market @ http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/regulation-policy/policy.

Contact sales(at)rnrmarketresearch(dot)com for further information.

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/ .) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/us-healthcare-policy/update-impact-analysis/prweb11403783.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The FDA is Pushing For Greater Restrictions on Prescription Painkillers: Now what?
2. Prescription opioid abusers prefer to get high on oxycodone and hydrocodone
3. Diet Doc Hormone Diets & Weight Loss Plans Announces New Specially Formulated Prescription Diet Pills Melting Pounds & Inches without Side Effects
4. Diet Doc Hormone Diets & Weight Loss Plans Introduce Weight Loss Supplements Containing Prescription Hormone Levels to Increase the Effectiveness of Paleo Diets
5. Diet Doc Hormone Diets and Weight Loss Plans Announces Uniquely Designed Prescription Diets for Rapid Weight Loss to Diminish Sleep Apnea and Heart Disease Risk
6. Diet Doc Hormone Diets & Weight Loss Plans Improve Human Heart Health With Prescription Hormone Diet Plans That Help Dieters Lose Weight Fast
7. Diet Doc Hormone Diets & Weight Loss Plans Announces Newly Improved, All Natural Prescription Hormone Diet Treatments that Target Body Fat for Fast Weight Loss
8. For many older adults, vision prescription differs between eyes
9. Prescription Acne Treatment Manufacturing in the US Industry Market Research Report from IBISWorld Has Been Updated
10. Prescription Drug Addiction Rises Among Elderly—Novus Medical Detox Calls for Rx Drug Education
11. Tampa Drug Detox Introduces Updated Women’s Program for Rehabilitation from Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... In this role, Courtney will be responsible ... the asthma & allergy friendly mark. This certification program was created by ASL and ... products to be more suitable for the 60+ million people living in the U.S. ...
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/15/2017)... ... January 15, 2017 , ... The ... is pleased to announce that it will be assisting HackensackUMC Mountainside with its ... Glen Ridge townships, servicing all surrounding towns. The firm will be working closely ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which allows ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , TransFreeze ... transition from one clip to the next. , To use “Cut-Out First” presets, ...
(Date:1/13/2017)... ... January 13, 2017 , ... KOAMTAC ®, Inc., a leading manufacturer of ... generation companion scanner and data collector at the National Retail Federation’s Big Show (NRF17) ... an answer to the market’s need for more compact and rugged devices for collecting ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... --  The Harrington Discovery Institute at University ... has announced the 2017 recipients of Harrington Scholar-Innovator ... whose research shows promise to advance the standard ... – part of The Harrington Project for Discovery ... medicine: to advance early breakthroughs into the clinical ...
(Date:1/16/2017)... Jan. 16, 2017 When synthetic Fentanyl arrived on ... product as top-rate. They offered free samples, inviting would-be customers ... Soon, business was booming. ... 100 times more powerful than morphine, has racked up a ... last 2 years. One dealer,s recorded fentanyl sales reveals that ...
(Date:1/16/2017)... According to the new market research report "Display Controller Market by Type ... Controller), Application (Industrial Control, Medical Equipment, Automotive, Mobile Communication), and Geography - ... grow from USD 17.26 Billion in 2015 to reach USD 32.24 Billion ... Continue Reading ... ...
Breaking Medicine Technology: